Juan P Arab1,2, Vijay H Shah1. Show Affiliations » 1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN. 2. Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Abstract
Entities: Disease
Mesh: See more » AnimalsBiopsy, NeedleDisease Models, AnimalDisease ProgressionHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHypertension, Portal/etiologyHypertension, Portal/physiopathologyHypertension, Portal/prevention & controlImmunohistochemistryLiver Cirrhosis/complicationsLiver Cirrhosis/pathologyLiver Cirrhosis/physiopathologyRatsRisk AssessmentTreatment Outcome
Substances: See more » Hydroxymethylglutaryl-CoA Reductase Inhibitors
Year: 2016 PMID: 27015447 DOI: 10.1002/hep.28567
Source DB: PubMed Journal: Hepatology ISSN: 0270-9139 Impact factor: 17.425